MYD88 and metabolic dysfunction-associated steatotic liver disease: After treated with AS-IV for 4 weeks, the levels of TLR4 mRNA, MyD88 mRNA, and NF-κB mRNA in the liver tissue of NAFLD rats were markedly restored at low dose, middle dose, and high dose of AS-IV.